MedPath

the Effectiveness of 3rd Occipital Radiofrequency Versus Systemic Steroid in Headache Management in Rheumatoid Arthritis

Not Applicable
Completed
Conditions
Rheumatoid Arthritis
Headache
Interventions
Drug: Radiofrequency
Drug: Steroids
Registration Number
NCT03852355
Lead Sponsor
Assiut University
Brief Summary

Rheumatoid arthritis is a common type of autoimmune arthritis that is characterized by inflammation of the synovial membranes. Even though any joint can be affected by the disease, cervical spine is often affected, and cervical pain is reported by 40-88% of RA patients, Cervical spine involvement is a feature of long-lasting disease, where atlantoaxial impaction with odontoid process vertical subluxation through the foramen magnum being one of the greatest and dangerous complications

Detailed Description

To our knowledge the effectiveness of 3rd occipital nerve blocks in managing chronic upper neck pain, headache in RA patients is not measured yet, so we aimed at assessing the the effectiveness of 3rd occipital nerve blocks in headache management in RA patients who used other medical agents and to compare the results with those of the patients who used only 3rd occipital nerve pulsed radiofrequancy on clinical and radiographic bases.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • patients suffering from upper neck pain and/or headache due to bilateral 3rd occipital nerve involvement evidenced by magnetic resonance imaging (MRI).
Exclusion Criteria
  • disc herniation with radicular pain,
  • symptomatic spinal stenosis,
  • surgical interventions of the cervical spine within the last 3 months,
  • uncontrolled major depression or psychiatric disorders,
  • heavy opioid usage

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RadiofrequencyRadiofrequencybilateral 3rd occipital nerve RF under fluoroscopic guidance
Systemic steroidSteroidsreceived systemic steroids oral prednisolone tablet, 10 mg/day.
Primary Outcome Measures
NameTimeMethod
neck disability index score6 months

maximum score = 50 worst paint , lowest score = no pain

Secondary Outcome Measures
NameTimeMethod
Severity of headache Visual analog scale6 months

maximum scale= 100 worst paint , lowest scale = no pain

Trial Locations

Locations (1)

Emad Zarief Kamel Said

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath